News

October 15, 2019October 15, 2019

Mutations in Alpha-Synuclein Speed Protein Clumping in Familial Parkinson’s and Affect Severity, Study Finds

News

A detailed analysis of alpha-synuclein — a key protein involved in Parkinson’s — revealed how variants of this protein change over time, allowing researchers to identify the initial stages ... Read more

October 15, 2019October 15, 2019

Safety and Efficacy of Oral Cannabidiol in Treating Parkinson’s Psychosis Focus of Phase 2 Study in UK

News

A planned Phase 2 clinical trial will assess the safety and effectiveness of pharmaceutical-grade cannabidiol (CBD) in treating Parkinson’s-related psychosis. The trial was announced by Parkinson’s UK, which is ... Read more

October 14, 2019October 14, 2019

Researchers Using Real-time Brain Mapping to Search for Therapeutic Targets in PD

News

Using its brain mapping platform, Inscopix will team up with researchers at the Broad Institute of MIT and Harvard to investigate how changes in brain activity alter the functioning ... Read more

October 14, 2019October 14, 2019

$20M Grant Awarded for Research into Imaging Protein Misfolding in Parkinson’s

News

The National Institute of Neurological Disorders and Stroke (NINDS) has awarded a five-year, $20 million grant to researchers looking for a way to image misfolded proteins in the brains ... Read more

October 11, 2019October 11, 2019

Genetic Parkinson’s More Common Than Thought, Global Survey Reveals

News

Cases of inherited Parkinson’s disease may be more frequent than previously reported, results from an online global survey suggest. The survey, which was conducted by members of The Michael ... Read more

October 11, 2019October 11, 2019

FIRE-UP PD Initiative Seeks to Increase Inclusivity in Parkinson’s Research

News

The Michael J. Fox Foundation (MJFF) and Massachusetts General Hospital have announced an initiative to enhance diversity in Parkinson’s disease research. Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson’s ... Read more

October 10, 2019October 10, 2019

Potential Treatment to Prevent Toxic Protein Clumping Enters Phase 1 Trial, Yumanity Announces

News

Yumanity Therapeutics announced the start of a Phase 1 clinical study in healthy volunteers that will assess the safety and tolerability of YTX-7739, a potential disease-modifying therapy for Parkinson’s disease. ... Read more

October 10, 2019October 10, 2019

MIT Scientists Building Artificial Gut to Study Bacteria’s Influence on Parkinson’s, Other Diseases

News

MIT Lincoln Laboratory researchers are developing an artificial gut to study how the human microbiome — the trillions of microorganisms and their genetic material that live within our body, ... Read more

October 9, 2019October 9, 2019

High Intensity Interval Training May Benefit Patients with Parkinson’s, Pilot Study Shows

News

High intensity interval training for 12 weeks can significantly improve neuronal activity and delay progression of Parkinson’s disease, correlating with an improvement in patients’ quality of life, according to ... Read more

October 9, 2019October 9, 2019

Middle-aged People Have Up to 20-Year Window to Reduce PD Risk, Oxford Health Policy Report Says

News

In calling for a public health campaign to promote a brain-healthy lifestyle, an Oxford Health Policy Forum report says people in middle age have a 10- to 20-year window of ... Read more

Pin It on Pinterest